Integrated Proteins Limited has submitted a regulatory disclosure to BSE Limited regarding the resignation of its Managing Director. The Board of Directors, at its meeting held on June 29, 2026, accepted the resignation of Mr. Karanj Dharmeshbhai Doshi (DIN: 10848249) from the position of Managing Director. The resignation is effective from the closure of business hours on June 29, 2026.
The stated reason for resignation is personal reasons and priorities, as mentioned in Mr. Doshi's resignation letter. The company specifically notes that there are no material reasons for the resignation other than those stated in the letter. The company has placed on record its appreciation for Mr. Doshi's services and contributions during his tenure.
As a result of this resignation, Mr. Doshi will cease to be a Key Managerial Person under the provisions of Section 203 of the Companies Act, 2013 and Regulation 30(5) of the SEBI Listing Regulations for determining materiality of events/information for disclosure to stock exchanges.
The disclosure is made pursuant to Regulation 30 read with Part A of Schedule II of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in compliance with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
The board meeting addressing this matter commenced at 17:45 HRS (IST) and concluded at 18:15 HRS (IST), lasting 30 minutes. The communication was signed by CS Shivangi Paliwal, Company Secretary and Compliance Officer (M.No.: A80556), on behalf of Integrated Proteins Limited.
Annexures
The disclosure includes two annexures:
- Annexure-A: Provides the detailed information required under amended Regulation 30 of SEBI LODR Regulations
- Annexure-B: Contains the resignation letter from Mr. Karanj Dharmeshbhai Doshi